Can Fite Biopharma Ltd (CANF) — Net Asset Momentum
Can Fite Biopharma Ltd (CANF) recorded a net asset momentum of 2.9% as of December 2025, with net assets of ILA5.59 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Can Fite Biopharma Ltd's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Can Fite Biopharma Ltd Net Asset Momentum (2003–2025)
This chart tracks Can Fite Biopharma Ltd's year-over-year net asset growth across 23 annual reporting periods from 2003 to 2025. The most recent momentum reading is +2.9%, with net assets of ILA5.59 Million ILA as of December 2025. For live market cap and overall valuation, see Can Fite Biopharma Ltd (CANF) total market value.
Annual Net Asset History for Can Fite Biopharma Ltd (2003–2025)
The table below shows the complete annual net asset history for Can Fite Biopharma Ltd from 2003 to 2025, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check CANF tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ILA5.59 Million | ILA9.52 Million | ILA3.92 Million | ▲ +2.9% |
| 2024 | ILA5.44 Million | ILA9.12 Million | ILA3.68 Million | ▼ -12.9% |
| 2023 | ILA6.24 Million | ILA9.99 Million | ILA3.75 Million | ▲ +39.6% |
| 2022 | ILA4.47 Million | ILA9.28 Million | ILA4.81 Million | ▼ -68.9% |
| 2021 | ILA14.38 Million | ILA20.25 Million | ILA5.87 Million | ▲ +136.8% |
| 2020 | ILA6.07 Million | ILA9.52 Million | ILA3.45 Million | ▲ +148.7% |
| 2019 | ILA2.44 Million | ILA8.17 Million | ILA5.73 Million | ▼ -19.0% |
| 2018 | ILA3.02 Million | ILA7.95 Million | ILA4.94 Million | ▼ -1.3% |
| 2017 | ILA3.05 Million | ILA7.83 Million | ILA4.78 Million | ▼ -21.2% |
| 2016 | ILA3.87 Million | ILA10.17 Million | ILA6.29 Million | ▼ -62.9% |
| 2015 | ILA10.44 Million | ILA17.60 Million | ILA7.16 Million | ▲ +52.3% |
| 2014 | ILA6.86 Million | ILA10.19 Million | ILA3.33 Million | ▲ +53.8% |
| 2013 | ILA4.46 Million | ILA6.63 Million | ILA2.18 Million | ▲ +729.7% |
| 2012 | ILA-707.99K | ILA1.64 Million | ILA2.34 Million | ▼ -121.5% |
| 2011 | ILA3.29 Million | ILA4.90 Million | ILA1.61 Million | ▼ -74.8% |
| 2010 | ILA13.07 Million | ILA18.55 Million | ILA5.47 Million | ▼ -3.1% |
| 2009 | ILA13.49 Million | ILA20.10 Million | ILA6.62 Million | ▼ -8.8% |
| 2008 | ILA14.79 Million | ILA21.86 Million | ILA7.07 Million | ▼ -61.8% |
| 2007 | ILA38.70 Million | ILA48.94 Million | ILA10.23 Million | ▲ +0.9% |
| 2006 | ILA38.34 Million | ILA41.76 Million | ILA3.42 Million | ▲ +7.0% |
| 2005 | ILA35.83 Million | ILA37.09 Million | ILA1.26 Million | ▲ +2082.8% |
| 2004 | ILA-1.81 Million | ILA1.28 Million | ILA3.09 Million | ▼ -187.3% |
| 2003 | ILA2.07 Million | ILA2.71 Million | ILA642.00K | — |